Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Ivy Tran, Nancy Abdallat, Mandisa Wen, Seema Patel, Misha Movahed-Ezazi, Arline Faustin, Marissa Spino-Keeton, Leah Geiser Roberts, Ekrem Maloku, Steven A Drexler, Benjamin L Liechty, David Pisapia, Olga Krasnozhen-Ratush, Marc Rosenblum, Seema Shroff, Daniel R Boué, Christian Davidson, Qinwen Mao, Mariko Suchi, Paula North, Amanda Hopp, Annette Segura, Jason A Jarzembowski, Lauren Parsons, Mahlon D Johnson, Bret Mobley, Wesley Samore, Declan McGuone, Pallavi P Gopal, Peter D Canoll, Craig Horbinski, Joseph M Fullmer, Midhat S Farooqui, Murat Gokden, Nitin R Wadhwani, Timothy E Richardson, Melissa Umphlett, Nadejda M Tsankova, John C DeWitt, Chandra Sen, Dimitris G Placantonakis, Donato Pacione, Jeffrey H Wisoff, Eveline Teresa Hidalgo, David Harter, Christopher M William, Christine Cordova, Sylvia C Kurz, Marissa Barbaro, Daniel A Orringer, Matthias A Karajannis, Erik P Sulman, Sharon L Gardner, David Zagzag, Aristotelis Tsirigos, Jeffrey C Allen, John G Golfinos, Matija Snuderl
BACKGROUND: Central nervous system (CNS) cancer is the 10th leading cause of cancer-associated deaths for adults, but the leading cause in pediatric patients and young adults. The variety and complexity of histologic subtypes can lead to diagnostic errors. DNA methylation is an epigenetic modification that provides a tumor type-specific signature that can be used for diagnosis. METHODS: We performed a prospective study using DNA methylation analysis as a primary diagnostic method for 1921 brain tumors...
2023: Neuro-oncology advances